Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Xtant Medical Holdings, Inc.Financial_Report.xls
EX-4.2 - EXHIBIT 4.2 - Xtant Medical Holdings, Inc.v402499_ex4-2.htm
EX-32.2 - EXHIBIT 32.2 - Xtant Medical Holdings, Inc.v402499_ex32-2.htm
EX-31.1 - EXHIBIT 31.1 - Xtant Medical Holdings, Inc.v402499_ex31-1.htm
EX-32.1 - EXHIBIT 32.1 - Xtant Medical Holdings, Inc.v402499_ex32-1.htm
EX-10.4 - EXHIBIT 10.4 - Xtant Medical Holdings, Inc.v402499_ex10-4.htm
EX-31.2 - EXHIBIT 31.2 - Xtant Medical Holdings, Inc.v402499_ex31-2.htm
EX-10.9 - EXHIBIT 10.9 - Xtant Medical Holdings, Inc.v402499_ex10-9.htm
EX-10.1 - EXHIBIT 10.1 - Xtant Medical Holdings, Inc.v402499_ex10-1.htm
EX-10.10 - EXHIBIT 10.10 - Xtant Medical Holdings, Inc.v402499_ex10-10.htm
10-K - 10-K - Xtant Medical Holdings, Inc.v402499_10k.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

 

We hereby consent to the incorporation by reference in Registration Statements on Form S-3 (No. 333-194944, No. 333-189830 and No. 333-175469) and on Form S-8 (No. 333-172891, No. 333-187563, and No. 333-191248) of Bacterin International Holdings, Inc. (the “Company”) of our report dated March 18, 2015 relating to the Company’s consolidated financial statements as of and for the year ended December 31, 2014, which report appears in Item 8 of this Form 10-K.

 

 

/s/ EKS&H LLLP

 

March 18, 2015

Denver, Colorado